Aura Biosciences, Inc. (AURA) stock
AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.11−0.50 (-6.57%)
Close on Nov 12, 2026Market cap $737.34MP/E –Yield –
Aura Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for Aura Biosciences
Aura Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?